Chemoinformaics analysis of HEXADECYL HEXADECANOATE
| Molecular Weight | 480.862 | nRot | 29 |
| Heavy Atom Molecular Weight | 416.35 | nRig | 1 |
| Exact Molecular Weight | 480.491 | nRing | 0 |
| Solubility: LogS | -3.055 | nHRing | 0 |
| Solubility: LogP | 3.155 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 98 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 64 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 32 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 97.7188 |
| nHD | 0 | BPOL | 66.8092 |
| QED | 0.574 |
| Synth | 1.874 |
| Natural Product Likeliness | 0.276 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.02 |
| Pgp-sub | 0.002 |
| HIA | 0.003 |
| CACO-2 | -4.233 |
| MDCK | 0.0000328 |
| BBB | 0.893 |
| PPB | 0.798398 |
| VDSS | 0.653 |
| FU | 0.210126 |
| CYP1A2-inh | 0.968 |
| CYP1A2-sub | 0.346 |
| CYP2c19-inh | 0.674 |
| CYP2c19-sub | 0.743 |
| CYP2c9-inh | 0.575 |
| CYP2c9-sub | 0.891 |
| CYP2d6-inh | 0.012 |
| CYP2d6-sub | 0.133 |
| CYP3a4-inh | 0.057 |
| CYP3a4-sub | 0.234 |
| CL | 12.477 |
| T12 | 0.801 |
| hERG | 0.033 |
| Ames | 0.007 |
| ROA | 0.056 |
| SkinSen | 0.737 |
| Carcinogencity | 0.311 |
| EI | 0.987 |
| Respiratory | 0.12 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.542149 |